Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Dworniczak, Leon
DOB: 13-APR-1978 (Age: 47)
Gender: male
ID: 8019-082775-0 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 19-DEC-2024

Problem list

Condition Onset Date Status
Anemia 14-Dec-2023 active
Chronic sinusitis 02-Oct-2022 active
Prediabetes 28-Dec-2017 active

Medication list

No known medications

Immunizations list

Vaccine Date
Clostridium tetani toxoid antigen adsorbed only vaccine product 19-Dec-2024
Influenza virus antigen only vaccine product 19-Dec-2024
Live attenuated Human alphaherpesvirus 3 only vaccine product 05-Sep-2024
SARS-CoV-2 mRNA vaccine 20-May-2021
Hepatitis A virus antigen only vaccine product 24-Dec-2015

Procedure History list

Procedure Date Reason
Medication reconciliation 05-Sep-2024 -
Assessment of health and social care needs 05-Sep-2024 -
Assessment of anxiety 05-Sep-2024 -
Screening for drug abuse 05-Sep-2024 -
Screening for domestic abuse 05-Sep-2024 -
Assessment of substance use 05-Sep-2024 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Diabetes self management plan 28-Dec-2017 Prediabetes
  • Patient will implement lifestyle modifications including healthy diet, regular physical activity, and weight management to reduce risk of progression to diabetes.
  • Patient will achieve and maintain a weight loss of at least 5% of baseline body weight.
  • Patient will engage in at least 150 minutes of moderate-intensity physical activity per week.

Vital Signs

Vital Signs 2024-12-19 2024-09-05
Body Height 181.4 cm 181.4 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} 3 {score}
Body Weight 97.6 kg 97 kg
Body mass index (BMI) [Ratio] 29.7 kg/m2 29.5 kg/m2
Diastolic Blood Pressure 83 mm[Hg] 80 mm[Hg]
Systolic Blood Pressure 136 mm[Hg] 131 mm[Hg]
Heart rate 90 /min 87 /min
Respiratory rate 15 /min 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 19-DEC-2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4 - 6 %
Glucose [Mass/volume] in Blood 79.2 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.3 7 - 43 mg/dL
Creatinine [Mass/volume] in Blood 1.3 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.8 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 106.1 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.8 22 - 29 mmol/L

Device Use

Device Date (since)
Home nebulizer (physical object) 01-Oct-2022
Blood glucose meter (physical object) 28-Dec-2017